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All genes DDR genes core DDR genes K FIGURE S1: Overview of alterations in DDR genes ( A ) Relative contribution of mutation sources computed using an improved, non-smooth NMF strategy (Covington et al., 2014) . This analysis used a total of 6,457 TCGA cancers having data from mutational signature, deleterious somatic mutation, deep deletion, and epigenetic silencing events. Equivalent COSMIC signature designations are given in the parentheses to the right. Signature analysis was done for 20 PanCan driver genes and 24 cancer type-specific driver genes. For genes other than POLE and MGMT , only positive associations with a FDR q-value < 0.01 and a fold change (altered vs. wildtype)of > 1.5 are shown. The 12 signatures that had no significant positive correlations with selected driver genes are not shown. The size of each filled circle corresponds to the absolute value of Log10 (FDR q-value) , and the color density of each filled circle corresponds to the absolute value of Log2 fold change. Genes and signatures of interest are further highlighted with black arrows and red rectangles. ( B -E ) Representative violin plots for POLE, MGMT, BRCA1 and EXO5 identified in (A). A thin box plot overlaid on each violin plot indicates signature minimum, median and maximum values as a function of gene alteration presence (ALT). M R E 1 1 A ( M R E 1 1 ) P A R P 1 ( P A R P C L E A V E D ) P A R P 1 ( P A R P 1 ) R A D 5 0 ( R A D 5 0 ) T P 5 3 B P 1 ( X 5 3 B P 1 )
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Up− and downregulation of protein levels of DDR genes with function mutations
T−statistic High expr. for mut .
Low expr. for mut . V411 and P286 (orange sphere) , another site of recurrent mutations. Though far apart in primary sequence, these two residues are in close proximity and are likely to affect the interaction between the exonuclease domain and the polymerase thumb. V411 is surrounded by a hydrogen bond network with both local and more distant contacts to residues separated in the primary sequence. (D) Molecular dynamics (MD) simulations reveal protein dynamics, where motions can be quantified using principal component (PC) analysis. Simulations are plotted in PC-space, where each point represents a POLE conformation and each mutation altered the sampling of PC motions. We visualized the first two PC motions using a cone at each alpha carbon atom. The first PC indicates the exonuclease domain and polymerase thumb moving towards (positive direction) or apart (negative direction) from one another. The second PC is largely defined by these two domains moving antiparallel to one another, with the polymerase fingers also moving parallel to the thumb. Both PCs also demonstrate movement of the N-terminal portion of the exonuclease domain with respect to the P-domain.
(E) MD simulations performed using native residues establish a reference point for assessing the effects of residue substitutions on protein dynamics (ΔPC). (F) MD simulations identify additional somatic mutations that may disrupt function by selectively altering protein dynamics.
MD simulations (n=86) for a subset of mutations were calculated. Many mutations that are not predicted to alter protein stability were predicted to alter protein dynamics. These mutations may alter function through a different underlying molecular mechanism than protein-destabilizing mutations. 
(A) Cancer types display a broad distribution of TP53 deep copy number loss and deleterious mutation events. Loss represents deep deletion events. The bottom bar indicates cancer types included during model training (teal fill). (B)
Cancer PFI) . N.S indicates no statistically significant association between the DDR score (y-axis) and cancer type (x-axis). Statistically significant associations with a Hazard Ratio (HR) of < 1 (where lower footprint scores are associated with worse outcomes) are indicated by green boxes, and those with HR > 1 (where higher footprint scores associated with worse outcomes) are indicated by brown boxes. Gray boxes indicate associations we could not evaluate due to missing data. BLCA  CESC  CHOL  COAD  ESCA  GBM  HNSC  KIRC  KIRP  LAML  LIHC  LUAD  LUSC  MESO  OV  PAAD  SARC  STAD  UCEC  UCS  UVM   rppa_ddr_score  tp53_score  RPS  PARPi7_bin  PARPi7  eCARD  HRD_Score  HRD_LOH  LST  TAI  subclonal_frac  genome_doublings  ploidy  LOH_frac_altered  LOH_burden  aneuploidy_score  n_extrema  frac_altered  n_segs  mutSig21  mutSig20  mutSig19  mutSig18  mutSig17  mutSig16  mutSig15  mutSig14  mutSig13  mutSig12  mutSig11  mutSig10  mutSig9  mutSig8  mutSig7  mutSig6  mutSig5  mutSig4  mutSig3  mutSig2  mutSig1  mutLoad_nonsilent This analysis used five different gene driver prediction tools to identify the subset of DDR genes deemed to be likely cancer drivers as indicated by one or more mutation-based driver prediction tools: 20/20+, CompositeDriver, MuSiC2, MutSig2CV and OncodriveFML. For each gene the "Tool(s)" column indicates the driver prediction tool(s) that identified this gene as a potential driver, and the "Cancer(s)" column indicates the cancer types (with specific cancer types indicated by their TCGA codes, or PANCAN for all the cancer samples combined) in which this gene was predicted to be a driver. 
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